<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11862328</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.615</article-id><article-id pub-id-type="other">EPP0475</article-id><article-id pub-id-type="pii">S0924933824006151</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Suicidal behaviour and intravenous drug use in chemsex context</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Curto Ramos</surname><given-names>J.</given-names></name><xref rid="aff1425" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff1426" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cor0476" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Rodr&#x000ed;guez Laguna</surname><given-names>A.</given-names></name><xref rid="aff1426" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Barrio</surname><given-names>P.</given-names></name><xref rid="aff1426" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ibarguchi</surname><given-names>L.</given-names></name><xref rid="aff1426" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Garc&#x000ed;a</surname><given-names>A.</given-names></name><xref rid="aff1426" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Azqueta</surname><given-names>I.</given-names></name><xref rid="aff1426" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Dolengevich Segal</surname><given-names>H.</given-names></name><xref rid="aff1427" ref-type="aff">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="aff1425"><sup>1</sup>Department of Psychiatry, Clinical Psychology and Mental Health, <institution>La Paz University Hospital</institution></aff><aff id="aff1426">
<sup>2</sup>
<institution>Apoyo Positivo</institution>
</aff><aff id="aff1427"><sup>3</sup>Dual Disorders Program. Department of Psychiatry, <institution>Henares University Hospital</institution>, <city>Madrid</city>, <country>Spain</country></aff><author-notes><corresp id="cor0476"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="590">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S295</fpage><lpage>S295</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824006151a.pdf"/><abstract><sec id="sec2859"><title>Introduction</title><p>Several studies have called atention to the mental health disorders associated with chemsex --the intentional use of drugs before or during sexual intercourse GBMSM (gay, bisexual and men who have sex with men) population-. Sexualized intravenous drug use is also known as slam or slamsex. There are few studies that analyze the mental health differences between intravenous drug users&#x000a0;compared to non-intravenous&#x000a0;drug users in chemsex context.</p></sec><sec id="sec2860"><title>Objectives</title><p>To describe the suicidal behaviour in a sample of users with sexualized drug use (chemsex) attended by the non-governmental organization Apoyo Positivo in the program &#x0201c;Sex, Drugs and You&#x0201d; and to compare the suicidal behaviour between intravenous drug users compared to non-intravenous drug users.</p></sec><sec id="sec2861"><title>Methods</title><p>A cross-sectional descriptive analysis of a sample of users attended by the non-governmental organization Apoyo Positivo in the program &#x0201c;Sex, Drugs and You&#x0201d; between 2016-2019 was performed.</p></sec><sec id="sec2862"><title>Results</title><p>We included 217 participants. 37 had attempted suicide at least once. The percentage of chemsex users who have attempted suicide were significantly higher in the intravenous drug use group compared to the non-intravenous drug use group (p&#x0003c;0.05).</p></sec><sec id="sec2863"><title>Conclusions</title><p>Possible risk factors for suicidal behaviour among chemsex users include slamsex. Other possible risk factors previously described in other studies include adversities experienced due to one&#x02019;s sexual orientation and an increased risk for HIV and other STI infections. Further studies analyzing the relationship between chemsex, slamsex and suicidal behaviour are needed.</p></sec><sec id="sec2864"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>